GeneDx Holdings Corp. (WGS)
NASDAQ: WGS · Real-Time Price · USD
135.38
-2.09 (-1.52%)
At close: Jan 9, 2026, 4:00 PM EST
135.38
0.00 (0.00%)
After-hours: Jan 9, 2026, 4:10 PM EST
GeneDx Holdings Market Cap
GeneDx Holdings has a market cap or net worth of $3.91 billion as of January 9, 2026. Its market cap has increased by 84.03% in one year.
Market Cap
3.91B
Enterprise Value
3.95B
1-Year Change
84.03%
Ranking
Category
Stock Price
$135.38
Market Cap Chart
Since November 4, 2020, GeneDx Holdings's market cap has decreased from $17.90B to $3.91B, a decrease of -78.14%. That is a compound annual growth rate of -25.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 8, 2026 | 3.97B | 5.70% |
| Dec 31, 2025 | 3.76B | 78.04% |
| Dec 31, 2024 | 2.11B | 2,866.28% |
| Dec 29, 2023 | 71.18M | -30.24% |
| Dec 30, 2022 | 102.04M | -90.52% |
| Dec 31, 2021 | 1.08B | -94.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 4, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 971.66B |
| Johnson & Johnson | 495.71B |
| AbbVie | 396.12B |
| UnitedHealth Group | 314.19B |
| AstraZeneca | 295.31B |
| Merck & Co. | 275.48B |
| Novartis AG | 273.11B |
| Novo Nordisk | 256.73B |